Dexpanthenol: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: February 27, 2026🚩 Report this page

Dexpanthenol

Active ingredient · 3 therapeutic classes

GB MHRA

Drug class: Other Plain Vitamin Preparations
Availability: See label
Markets covered: 1
Products on record: 1

A11HAOther Plain Vitamin Preparations D03AXOther Cicatrizants S01XAOther Ophthalmologicals

Overview

Dexpanthenol is an active pharmaceutical ingredient in the Other Plain Vitamin Preparations group (A11HA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	1	February 27, 2026

GBUnited Kingdom· MHRA

1 product

Uses

GBOfficial regulatory label· revised February 27, 2026[1]

1).

How to take

GBOfficial regulatory label· revised February 27, 2026

Sources & citations

[1]MHRA (UK) · PL155130407 · revised February 27, 2026

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised February 27, 2026[1]

The following definitions apply to the incidence of the undesirable effects: - Very common (≥ 1/10) - Common (≥ 1/100 to < 1/10) - Uncommon (≥ 1/1,000 to < 1/100) - Rare (≥ 1/10,000 to < 1/1,000) - Very rare (< 1/10,000) - Not known (cannot be estimated from the available data) Tabulated list of adverse reactions Uncommon Rare Very rare Not known Immune system Disorders hypersensitivity reaction (angioedema, skin rash, pruritus)Psychiatric disorders, especially with prolonged and/or heavy use.
restlessness, insomnia, hallucinations and paranoid delusions. irritability, anxiety, excitability Nervous system Disorders fatigue (drowsiness, sedation), headache, convulsions Cardiac disorders, especially with prolonged and/or heavy use palpitations, tachycardia, hypertension arrhythmias Respiratory, thoracic and mediastinal disorders rebound congestion (rhinitis medicamentosa) - especially with prolonged and/or heavy use, nosebleed Sneezing, burning, irritation and dryness of the nasal mucosa.
) Reporting of suspected adverse reactions Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised February 27, 2026[1]

4 Special warnings and pre cautions for us e There is minimal systemic absorption with topically applied imidazoline sympathomimetics such as xylometazoline. This medicinal product may be used only after a careful assessment of the risks and benefits in cases of: - increased intraocular pressure - porphyria - prostate hyperplasia.
Use during chronic rhinitis may only be carried out under medical supervision owing to the danger of the atrophy of the nasal mucosa. Use with caution in occlusive vascular disease. Patients with long QT syndrome treated with xylometazoline may be at increased risk of serious ventricular arrhythmias.
This medicine is intended for short term use only. Prolonged treatment may lead to reactive hyperaemia of the nasal mucosa. 8). Keep away from the eyes. 9). If any of the following occur, use of Sudafed Plus Blocked Nose Spray should be stopped: - Hallucinations - Restlessness - Sleep disturbances

This is not medical advice. Consult a qualified healthcare professional.

Overview

Regulatory status by market

GBUnited Kingdom· MHRA

Drugs in the same class

Sources & citations